deltatrials

Recurrent childhood acute lymphoblastic leukemia Trials in Atlanta, United States

Conditions / Recurrent childhood acute lymphoblastic leukemia / Atlanta, United States

Recurrent childhood acute lymphoblastic leukemia has been the subject of sustained clinical investigation across multiple research sites.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID Title Status Phase
NCT01154816 Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia COMPLETED PHASE2
NCT01817075 Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant COMPLETED PHASE3
NCT00897325 Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma COMPLETED
NCT00105001 Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer COMPLETED PHASE2
NCT01231919 MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia COMPLETED PHASE1
NCT00098839 Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) COMPLETED PHASE1/PHASE2
NCT00873093 Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma COMPLETED PHASE2
NCT01371656 Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation COMPLETED PHASE3
NCT00078858 Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant COMPLETED PHASE1/PHASE2
NCT01305200 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant COMPLETED PHASE3

Related Pages